| The striking effect of the Heart Outcomes Prevention Evaluation (HOPE) on ramipril prescribing in Ontario. | |
| | |
MedLine Citation:
|
PMID: 12615747 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: The Heart Outcomes Prevention Evaluation (HOPE), a Canadian-led, multicentre, randomized controlled trial, demonstrated the effectiveness of the ACE inhibitor ramipril in the secondary prevention of cardiovascular disease in patients who were at high risk for cardiovascular events but did not have left ventricular dysfunction or heart failure. We studied whether HOPE affected the prescribing of ACE inhibitors generally, and ramipril specifically, in Ontario, where the trial was coordinated. METHODS: We used linked administrative databases to examine prescribing patterns for ACE inhibitors in the 1.29 million to 1.54 million elderly (aged 66 and over) residents of Ontario during the study period and specifically those with diabetes or congestive heart failure. For all new prescriptions for these drugs filled between Jan. 1, 1993, and Mar. 31, 2001, we conducted time-series analyses to measure any association with the release of the HOPE results. RESULTS: The monthly number of new prescriptions for ramipril from the time it was introduced in 1995 until HOPE's early termination, in April 1999, peaked at 58 per 100,000 elderly Ontario residents. The rate increased to 92/100,000 in May, coincident with newspaper coverage of the trial's early termination, then fell back to 63/100,000 in August. After HOPE's results were formally released, starting Aug. 31, the rate increased significantly; it peaked at 304/100,000 in May 2000 (p < 0.01). The market share of ramipril among ACE inhibitors also increased significantly (p < 0.01), both overall and among patients with diabetes or congestive heart failure. INTERPRETATION: HOPE led to a striking and unprecedented increase, over 400%, in ramipril prescribing to elderly Ontario residents, including those not eligible for the trial. Many physicians are now prescribing ramipril for patients with diabetes or congestive heart failure. |
| | |
Authors:
|
Karen Tu; Muhammad M Mamdani; Robert M Jacka; Natalie J Forde; Deanna M Rothwell; Jack V Tu |
Related Documents
:
|
646547 - Hydralazine-induced tachycardia and sodium retention in heart failure. hemodynamic and ... 8974067 - Human myocardial na,k-atpase concentration in heart failure. 17723937 - Valve pathology in heart failure: which valves can be fixed? 17119377 - Increased levels of cardiac troponin-t in outpatients with heart failure and preserved ... 1533257 - Unique responses of immature hearts to ischemia. functional recovery versus initiation ... 19306437 - Normal right ventricular three-dimensional architecture, as assessed with diffusion ten... |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne Volume: 168 ISSN: 0820-3946 ISO Abbreviation: CMAJ Publication Date: 2003 Mar |
Date Detail:
|
Created Date: 2003-03-04 Completed Date: 2003-04-01 Revised Date: 2009-11-18 |
Medline Journal Info:
|
Nlm Unique ID: 9711805 Medline TA: CMAJ Country: Canada |
Other Details:
|
Languages: eng Pagination: 553-7 Citation Subset: AIM; IM |
Affiliation:
|
Institute for Clinical Evaluative Sciences, University Health Network-Toronto Western Hospital Family Medicine Center and Department of Family and Community Health-Family Health Research Unit, University of Toronto, Toronto, ON. karen@ices.on.ca |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Angiotensin-Converting Enzyme Inhibitors / therapeutic use* Cardiovascular Diseases / prevention & control* Databases, Factual Drug Utilization Humans Ontario Ramipril / therapeutic use* Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Angiotensin-Converting Enzyme Inhibitors; 87333-19-5/Ramipril |
| Comments/Corrections | |
Comment In:
|
CMAJ. 2003 Jun 24;168(13):1647; author reply 1647-8
[PMID:
12821617
]
CMAJ. 2003 Jun 24;168(13):1646; author reply 1647-8 [PMID: 12821614 ] CMAJ. 2003 Mar 4;168(5):568-9 [PMID: 12615751 ] |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Depression and prognosis following hospital admission because of acute myocardial infarction.
Next Document: Severe hydrocephalus associated with congenital varicella syndrome.